Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA-KIDNEY
EMPA-KIDNEY assessed the effects of empagliflozin 10 mg once daily vs. placebo in 6609 patients with chronic kidney disease (CKD) at risk of progression, including 612 participants from Japan.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2024
|
| In: |
Clinical and experimental nephrology
Year: 2024, Jahrgang: 28, Heft: 6, Pages: 588-595 |
| ISSN: | 1437-7799 |
| DOI: | 10.1007/s10157-024-02489-4 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s10157-024-02489-4
|
| Verfasserangaben: | Masaomi Nangaku, William G. Herrington, Shinya Goto, Shoichi Maruyama, Naoki Kashihara, Kohjiro Ueki, Jun Wada, Hirotaka Watada, Eitaro Nakashima, Ryonfa Lee, Dan Massey, Kaitlin J. Mayne, Aiko Tomita, Richard Haynes, Sibylle J. Hauske, Takashi Kadowaki |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1907178538 | ||
| 003 | DE-627 | ||
| 005 | 20241220171137.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 241030s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10157-024-02489-4 |2 doi | |
| 035 | |a (DE-627)1907178538 | ||
| 035 | |a (DE-599)KXP1907178538 | ||
| 035 | |a (OCoLC)1475637010 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Nangaku, Masaomi |e VerfasserIn |0 (DE-588)1346577579 |0 (DE-627)1907178910 |4 aut | |
| 245 | 1 | 0 | |a Effects of empagliflozin in patients with chronic kidney disease from Japan |b exploratory analyses from EMPA-KIDNEY |c Masaomi Nangaku, William G. Herrington, Shinya Goto, Shoichi Maruyama, Naoki Kashihara, Kohjiro Ueki, Jun Wada, Hirotaka Watada, Eitaro Nakashima, Ryonfa Lee, Dan Massey, Kaitlin J. Mayne, Aiko Tomita, Richard Haynes, Sibylle J. Hauske, Takashi Kadowaki |
| 264 | 1 | |c 2024 | |
| 300 | |b 1 Illustration | ||
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 20. April 2024 | ||
| 500 | |a Gesehen am 30.10.2024 | ||
| 520 | |a EMPA-KIDNEY assessed the effects of empagliflozin 10 mg once daily vs. placebo in 6609 patients with chronic kidney disease (CKD) at risk of progression, including 612 participants from Japan. | ||
| 650 | 4 | |a Cardiovascular disease | |
| 650 | 4 | |a Kidney function | |
| 650 | 4 | |a Randomised trial | |
| 650 | 4 | |a Sodium-glucose co-transporter-2 inhibitor | |
| 700 | 1 | |a Herrington, William G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Goto, Shinya |e VerfasserIn |4 aut | |
| 700 | 1 | |a Maruyama, Shoichi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kashihara, Naoki |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ueki, Kohjiro |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wada, Jun |e VerfasserIn |4 aut | |
| 700 | 1 | |a Watada, Hirotaka |e VerfasserIn |4 aut | |
| 700 | 1 | |a Nakashima, Eitaro |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lee, Ryonfa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Massey, Dan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mayne, Kaitlin J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tomita, Aiko |e VerfasserIn |4 aut | |
| 700 | 1 | |a Haynes, Richard |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hauske, Sibylle J. |d 1976-2025 |e VerfasserIn |0 (DE-588)137856253 |0 (DE-627)596151527 |0 (DE-576)305349686 |4 aut | |
| 700 | 1 | |a Kadowaki, Takashi |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical and experimental nephrology |d [Tokyo] : Springer, 1997 |g 28(2024), 6, Seite 588-595 |h Online-Ressource |w (DE-627)306646900 |w (DE-600)1499111-1 |w (DE-576)113948530 |x 1437-7799 |7 nnas |a Effects of empagliflozin in patients with chronic kidney disease from Japan exploratory analyses from EMPA-KIDNEY |
| 773 | 1 | 8 | |g volume:28 |g year:2024 |g number:6 |g pages:588-595 |g extent:8 |a Effects of empagliflozin in patients with chronic kidney disease from Japan exploratory analyses from EMPA-KIDNEY |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10157-024-02489-4 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20241030 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 137856253 |a Hauske, Sibylle J. |m 137856253:Hauske, Sibylle J. |d 60000 |d 61400 |e 60000PH137856253 |e 61400PH137856253 |k 0/60000/ |k 1/60000/61400/ |p 15 | ||
| 999 | |a KXP-PPN1907178538 |e 4608336584 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Nangaku","role":"aut","given":"Masaomi","display":"Nangaku, Masaomi"},{"family":"Herrington","display":"Herrington, William G.","given":"William G.","role":"aut"},{"family":"Goto","display":"Goto, Shinya","role":"aut","given":"Shinya"},{"family":"Maruyama","given":"Shoichi","role":"aut","display":"Maruyama, Shoichi"},{"family":"Kashihara","display":"Kashihara, Naoki","given":"Naoki","role":"aut"},{"given":"Kohjiro","role":"aut","display":"Ueki, Kohjiro","family":"Ueki"},{"display":"Wada, Jun","role":"aut","given":"Jun","family":"Wada"},{"family":"Watada","display":"Watada, Hirotaka","role":"aut","given":"Hirotaka"},{"display":"Nakashima, Eitaro","given":"Eitaro","role":"aut","family":"Nakashima"},{"family":"Lee","display":"Lee, Ryonfa","given":"Ryonfa","role":"aut"},{"given":"Dan","role":"aut","display":"Massey, Dan","family":"Massey"},{"role":"aut","given":"Kaitlin J.","display":"Mayne, Kaitlin J.","family":"Mayne"},{"family":"Tomita","given":"Aiko","role":"aut","display":"Tomita, Aiko"},{"family":"Haynes","display":"Haynes, Richard","role":"aut","given":"Richard"},{"family":"Hauske","given":"Sibylle J.","role":"aut","display":"Hauske, Sibylle J."},{"display":"Kadowaki, Takashi","given":"Takashi","role":"aut","family":"Kadowaki"}],"name":{"displayForm":["Masaomi Nangaku, William G. Herrington, Shinya Goto, Shoichi Maruyama, Naoki Kashihara, Kohjiro Ueki, Jun Wada, Hirotaka Watada, Eitaro Nakashima, Ryonfa Lee, Dan Massey, Kaitlin J. Mayne, Aiko Tomita, Richard Haynes, Sibylle J. Hauske, Takashi Kadowaki"]},"relHost":[{"disp":"Effects of empagliflozin in patients with chronic kidney disease from Japan exploratory analyses from EMPA-KIDNEYClinical and experimental nephrology","physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1437-7799"],"zdb":["1499111-1"],"eki":["306646900"]},"note":["Gesehen am 25.08.20"],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"306646900","origin":[{"dateIssuedKey":"1997","dateIssuedDisp":"1997-","publisher":"Springer ; Churchill Livingstone Japan","publisherPlace":"[Tokyo] ; Tokyo"}],"title":[{"subtitle":"official publication of the Japanese Society of Nephrology","title":"Clinical and experimental nephrology","title_sort":"Clinical and experimental nephrology"}],"part":{"volume":"28","text":"28(2024), 6, Seite 588-595","year":"2024","issue":"6","extent":"8","pages":"588-595"},"language":["eng"],"pubHistory":["1.1997 -"]}],"note":["Online veröffentlicht: 20. April 2024","Gesehen am 30.10.2024"],"id":{"eki":["1907178538"],"doi":["10.1007/s10157-024-02489-4"]},"physDesc":[{"extent":"8 S.","noteIll":"1 Illustration"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"2024"}],"recId":"1907178538","language":["eng"],"title":[{"title_sort":"Effects of empagliflozin in patients with chronic kidney disease from Japan","title":"Effects of empagliflozin in patients with chronic kidney disease from Japan","subtitle":"exploratory analyses from EMPA-KIDNEY"}]} | ||
| SRT | |a NANGAKUMASEFFECTSOFE2024 | ||